Home

Pontosság újság kérés tia aspirin jegyző Borotva Kerékagy

A Comparison of Two Doses of Aspirin (30 mg vs. 283 mg a Day) in Patients  after a Transient Ischemic Attack or Minor Ischemic Stroke | NEJM
A Comparison of Two Doses of Aspirin (30 mg vs. 283 mg a Day) in Patients after a Transient Ischemic Attack or Minor Ischemic Stroke | NEJM

Dual antiplatelet therapy with ticagrelor may increase the risk of all  bleeding events in patients with minor strokes or high risk TIAs: a  meta-analysis | Stroke and Vascular Neurology
Dual antiplatelet therapy with ticagrelor may increase the risk of all bleeding events in patients with minor strokes or high risk TIAs: a meta-analysis | Stroke and Vascular Neurology

Efficacy of Clopidogrel-Aspirin Regimen for TIA and Minor Stroke | Download  Table
Efficacy of Clopidogrel-Aspirin Regimen for TIA and Minor Stroke | Download Table

Life | Free Full-Text | Antithrombotic Therapy for Secondary Prevention in  Patients with Non-Cardioembolic Stroke or Transient Ischemic Attack: A  Systematic Review
Life | Free Full-Text | Antithrombotic Therapy for Secondary Prevention in Patients with Non-Cardioembolic Stroke or Transient Ischemic Attack: A Systematic Review

Dual antiplatelet Tx for stroke prevention: Worth the risk? | MDedge Family  Medicine
Dual antiplatelet Tx for stroke prevention: Worth the risk? | MDedge Family Medicine

290 Stroke and TIA Triple Distilled - The Curbsiders
290 Stroke and TIA Triple Distilled - The Curbsiders

Ticagrelor and Aspirin versus Aspirin in Acute Ischemic Stroke or TIA | NEJM
Ticagrelor and Aspirin versus Aspirin in Acute Ischemic Stroke or TIA | NEJM

Clopidogrel and Aspirin in Acute Ischemic Stroke and High‐Risk TIA |  Semantic Scholar
Clopidogrel and Aspirin in Acute Ischemic Stroke and High‐Risk TIA | Semantic Scholar

Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin  in Patients With Acute Ischemic Stroke or Transient Ischemic Attack | Stroke
Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack | Stroke

Drugs in secondary stroke prevention
Drugs in secondary stroke prevention

Ticagrelor, aspirin benefits in TIA outweigh risk over 30-day treatment  period: Neurology
Ticagrelor, aspirin benefits in TIA outweigh risk over 30-day treatment period: Neurology

Stroke Guidelines | The International Aspirin Foundation
Stroke Guidelines | The International Aspirin Foundation

THALES: Ticagrelor Plus Aspirin Cuts Repeat Events After Stroke, TIA |  tctmd.com
THALES: Ticagrelor Plus Aspirin Cuts Repeat Events After Stroke, TIA | tctmd.com

VisualAbstract: Ticagrelor and aspirin vs. aspirin alone for ischemic  stroke or TIA | 2 Minute Medicine
VisualAbstract: Ticagrelor and aspirin vs. aspirin alone for ischemic stroke or TIA | 2 Minute Medicine

Current Recommendations for Secondary Stroke Prevention
Current Recommendations for Secondary Stroke Prevention

Primary and Secondary Prevention of Ischemic Stroke and Cerebral  Hemorrhage: JACC Focus Seminar - ScienceDirect
Primary and Secondary Prevention of Ischemic Stroke and Cerebral Hemorrhage: JACC Focus Seminar - ScienceDirect

Immediate aspirin after mini-stroke substantially reduces risk of major  stroke | University of Oxford
Immediate aspirin after mini-stroke substantially reduces risk of major stroke | University of Oxford

Cuidados intensivos - Apurímac - Dual Antiplatelet Therapy Versus Aspirin  in Patients With #Stroke or Transient Ischemic Attack: Meta-Analysis of  Randomized Controlled Trials #TIA #AHAJournals http://ow.ly/J9bu50EC3Fo |  Facebook
Cuidados intensivos - Apurímac - Dual Antiplatelet Therapy Versus Aspirin in Patients With #Stroke or Transient Ischemic Attack: Meta-Analysis of Randomized Controlled Trials #TIA #AHAJournals http://ow.ly/J9bu50EC3Fo | Facebook

Abbreviations: ACS indicates acute coronary syndrome; TIA, transient... |  Download Scientific Diagram
Abbreviations: ACS indicates acute coronary syndrome; TIA, transient... | Download Scientific Diagram

EMNote.org - EMNote
EMNote.org - EMNote

Dual Antiplatelet Therapy for High-Risk TIA and Minor Stroke: BMJ Rapid  Recommendation | AAFP
Dual Antiplatelet Therapy for High-Risk TIA and Minor Stroke: BMJ Rapid Recommendation | AAFP

THALES Secondary Efficacy | BRILINTA® (ticagrelor) tablets | For HCPs
THALES Secondary Efficacy | BRILINTA® (ticagrelor) tablets | For HCPs

Dual Antiplatelet Therapy Versus Aspirin in Patients With Stroke or Transient  Ischemic Attack: Meta-Analysis of Randomized Controlled Trials | Stroke
Dual Antiplatelet Therapy Versus Aspirin in Patients With Stroke or Transient Ischemic Attack: Meta-Analysis of Randomized Controlled Trials | Stroke

Stroke Guidelines | The International Aspirin Foundation
Stroke Guidelines | The International Aspirin Foundation

Antithrombotic therapy by cause of TIA - UpToDate
Antithrombotic therapy by cause of TIA - UpToDate

Contraindications to aspirin in suspected TIA | Download Table
Contraindications to aspirin in suspected TIA | Download Table